ICNMD 2026

Sponsorship & Exhibits

ICNMD is an excellent opportunity to interact with a diverse group of clinicians, scientists, students, and industry professionals involved with muscular dystrophies, other myopathies, myasthenia gravis, polyneuropathies, spinal cord disorders, and neurofibromatosis, to list only a few. Over 1,000 clinicians and scientists from around the world are expected to attend.

Increase your visibility and organization’s exposure to national and international markets by becoming a sponsor and/or exhibitor or by holding an industry-supported symposium at this outstanding and important Congress.

Please see below for background information and for the link to request our sponsorship brochure.

The Congress is pleased to offer a variety of options, including but not limited to:

  • Industry-supported seminars
  • Print, digital and onsite advertising opportunities
  • Exhibit booths
  • and more…

To receive more details on how to sponsor or exhibit at our event, please fill out our Brochure Request Form.

Statistics on Current and Past Editions

Event Attendance

YearVenueAttendanceYearVenueAttendance
2026Florence, Italy1,500 exp.2018Vienna, Austria1,400
2024Perth, Australia7322016Toronto, Canada800
2022Brussels, Belgium1,2502014Nice, France900
2021Virtual, worldwide1,3502010Naples, Italy800

Demographics & Statistics

Regional statistics from past ICNMD editions:

ICNMD 2024 
(Australia, Asia)
ICNMD 2022
(Belgium, Europe)
ICNMD 2018
(Austria, Europe)
ICNMD 2016 
(Canada, North America)
  • Asia & Australasia 66% 
  • Europe 16% 
  • North America 16% 
  • Middle East & Africa 2% 
  • Latin America 1% 
  • Europe 74%
  • North America 15%
  • Asia 5%
  • Latin America 4%
  • Middle East & Africa 2%
  • Europe 66%
  • North America 17%
  • Asia 11%
  • Middle East & Africa 4%
  • Latin America 2%
  • North America 66% 
  • Europe 19% 
  • Asia 9% 
  • Middle East & Africa 3% 
  • Latin America 3% 

Category statistics from past ICNMD editions:

ICNMD 2024 
(Australia, Asia)
ICNMD 2022
(Belgium, Europe)
ICNMD 2018
(Austria, Europe)
ICNMD 2016
(Canada, North America)
  • Healthcare Professionals 59% 
  • Industry 33% 
  • Academics (non-HCP) 7% 
  • Patient Organizations 1% 
  • Healthcare Professionals 47%
  • Industry 37%
  • Academics (non HCP) 7%
  • Patient Organizations 1%
  • Other 8%
  • Healthcare Professionals 36%
  • Industry 33%
  • Academics * 23%
  • Patient organizations 1%
  • Other 8%
  • Healthcare Professionals 40%
  • Industry 33%
  • Academics * 12%
  • Patient organizations 7%
  • Other 7%

* Some (most) of which are HCP

  • Alexion Pharmaceuticals (AstraZeneca) 
  • Alnylam Pharmaceuticals 
  • Amylyx Pharmaceuticals 
  • Annexon Biosciences 
  • Apellis Pharmaceuticals 
  • argenx 
  • Astellas Gene Therapies 
  • Augustine Therapeutics 
  • Avidity Biosciences 
  • Biogen 
  • BioMarin Pharmaceutical 
  • Cadwell Industries 
  • Canon / Toshiba Medical Systems 
  • Cerevel Therapeutics (AbbVie) 
  • CSL Behring 
  • Dyne Therapeutics 
  • Fulcrum Therapeutics 
  • GE Healthcare 
  • GeneDx 
  • Grifols 
  • Grupo Ferrer 
  • Idera Pharmaceuticals 
  • Italfarmaco 
  • iThera Medical 
  • Johnson & Johnson Innovative Medicine (Janssen) 
  • LFB Biomedicaments 
  • LifeLabs Genetics 
  • Lupin Neurosciences 
  • Medison Pharma 
  • Merck 
  • Novartis Gene Therapies 
  • Octapharma 
  • Percheron Therapeutics 
  • Pfizer 
  • Pharnext 
  • Philips Healthcare 
  • PTC Therapeutics 
  • Roche 
  • Sanofi Genzyme 
  • Santhera Pharmaceuticals 
  • Sarepta Therapeutics 
  • Scholar Rock 
  • SERB Specialty Pharmaceuticals 
  • Takeda Pharmaceuticals 
  • UCB Biopharma 

Contact Us

Please contact our dedicated Sponsorship & Exhibits Sales Manager for more information on our sponsorship and exhibits options, and to start discussing how you would like to support and be involved in ICNMD.

Mrs. Cali (Carine) Vindeirinho
Senior Sponsorship & Exhibits Sales Manager
ICNMD-Sponsorship(at)icsevents.com
Direct: [+1] 604 639 3919
Office: [+1] 604 681 2153 x 138